P-50 Prognostic factors in patients receiving trifluridine/tipiracil for refractory metastatic colorectal cancer in the real-life setting: The ROS study

Authors :: F. Rivera Herrero
V. Alonso Orduña
C. Grávalos Castro
E. Mata Velasco
M.T. Delgado Urena
R. Grandez
M.J. Safont Aguilera
Marta Llanos
Enrique Aranda
P. García-Alfonso
A. Illán Varella
J. J. Reina Zoilo
I. Fernandez Rañada
J. Rodriguez-Pascual
Mireia Moreno
J. Mendez
P. Pimentel
C. Castañón
Beatriz García-Paredes
R. Afonso
I. Siso
A.M. López Muñoz
Source :: Annals of Oncology. 32:S113
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Refractory
business.industry
Colorectal cancer
Internal medicine
Medicine
In patient
Hematology
business
medicine.disease
Real life setting

Tools